Ana Beatriz Santana Sousa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana Beatriz Santana Sousa has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- João Marcelo de Castro e Sousa
Federal University of Piaui
2 shared publications - Nicole Debia
Federal University of Piaui
2 shared publications - Paulo Michel Pinheiro Ferreira
Federal University of Piaui
2 shared publications - Victor Alves de Oliveira
Universidade Federal do Piauí
2 shared publications - Athanara Alves de Sousa
Federal University of Piaui
1 shared publication - Beatriz Arêa Cassiano de Melo
Federal University of Piaui
1 shared publication
Latest Publications
- 19 May 2025
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 88 (18) , 727-747
Toxicological safety, antioxidant effect, and chemoprotection determination of an extract from the babassu mesocarp ( Orbignya phalerata Mart.) in preclinical studies
Reactive nitrogen species (RNS) and reactive oxygen species (ROS) play a key role in chronic diseases and aging by initiating protein oxidation, impaired cellular membrane damage and functions, and induction of DNA mutations. When endogenous antioxidants are insufficient to counteract oxidant stress, bioactive compounds might serve as physiological therapeutic agents attributed to their ability to neutralize ROS. The aim of this study was to examine the antioxidant, chemoprotective and toxicological aspects of the hydroethanolic extract from Orbignya phalerata Mart. mesocarp using in vitro and in vivo bioassays. The extract presented 9.9 mg/g of total flavonoids, primarily catechin and epicatechin. This extract exhibited no apparent toxicity upon Artemia salina (LC50 > 1000 μg/ml) or Zophobas morio larvae (LD50 > 3000 mg/kg), low hemolysis, genotoxicity, or mutagenicity utilizing Allium cepa cells. Cytotoxicity effects were observed on in L-929 murine fibroblast only at concentrations above 130 μg/ml. This extract effectively neutralized free radicals [DPPH• (EC50 25.3 μg/ml) and ABTS•+ (EC50 52.6 μg/ml)] and reduced H2O2-initiated effects on Saccharomyces cerevisiae. The chemoprotective activity of this extract was also noted in A. salina, L-929 cells, and S. cerevisiae as evidenced from oxidative damage and toxicity tests results. This constitutes the first report describing the toxicological safety profile of a babassu mesocarp extract a rich source of flavonoids (catechin and epicatechin) with antioxidant and chemoprotective activities.
- 19 May 2025
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 88 (18) , 727-747
Toxicological safety, antioxidant effect, and chemoprotection determination of an extract from the babassu mesocarp ( Orbignya phalerata Mart.) in preclinical studies
Reactive nitrogen species (RNS) and reactive oxygen species (ROS) play a key role in chronic diseases and aging by initiating protein oxidation, impaired cellular membrane damage and functions, and induction of DNA mutations. When endogenous antioxidants are insufficient to counteract oxidant stress, bioactive compounds might serve as physiological therapeutic agents attributed to their ability to neutralize ROS. The aim of this study was to examine the antioxidant, chemoprotective and toxicological aspects of the hydroethanolic extract from Orbignya phalerata Mart. mesocarp using in vitro and in vivo bioassays. The extract presented 9.9 mg/g of total flavonoids, primarily catechin and epicatechin. This extract exhibited no apparent toxicity upon Artemia salina (LC50 > 1000 μg/ml) or Zophobas morio larvae (LD50 > 3000 mg/kg), low hemolysis, genotoxicity, or mutagenicity utilizing Allium cepa cells. Cytotoxicity effects were observed on in L-929 murine fibroblast only at concentrations above 130 μg/ml. This extract effectively neutralized free radicals [DPPH• (EC50 25.3 μg/ml) and ABTS•+ (EC50 52.6 μg/ml)] and reduced H2O2-initiated effects on Saccharomyces cerevisiae. The chemoprotective activity of this extract was also noted in A. salina, L-929 cells, and S. cerevisiae as evidenced from oxidative damage and toxicity tests results. This constitutes the first report describing the toxicological safety profile of a babassu mesocarp extract a rich source of flavonoids (catechin and epicatechin) with antioxidant and chemoprotective activities.
- Open Access
- 31 January 2024
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 10 (1) , 1-22
Comprehensive preclinical studies on the bioactivity of Orbignya phalerata Mart. (Babassu) and its derived products: a systematic review
Background: Babassu (Orbignya phalerata Mart.) is a palm tree well distributed in Latin America, whose fruit has a mesocarp and kernel used for human feeding, and empirically related to the treatment of gastritis, vaginitis, and wound healing. Main body of the The activities attributed to babassu can guide new research on health applications and, for this reason, this study aimed to report in vitro and in vivo biological activities of O. phalerata constituents through a systematic review. Searches terms were applied in five world databases and the data from the publications were collected according to PICOS criteria, including the fruit component, concentration/dose, time of exposure, and comparative groups. All outcomes were reported and the most relevant outcomes were described by a narrative synthesis and a risk of bias assessment. A total of 28 in vitro (n = 15) and in vivo (n = 11) studies were included, and two showed both experimental designs. The studies were heterogeneous, with the predominance of metabolic analysis, wound and peptic ulcer healing, besides in vivo toxicity, among others. For in vitro analysis, antioxidant tests, cell viability and antimicrobial activity predominated. All in vivo ones used rodents. Meanwhile, tumor and non-tumor cell lines, bacteria strains, Leishmania amazonensis, Artemia salina, and antioxidant reactions were considered for in vitro protocols. Short conclusion: The most frequent applications included mesocarp and kernel in a wide range of extracts, emulsions, and concentrations. Their low in vitro lethality and cytotoxicity, and no acute toxicity in vivo open possibilities for the development of long-term toxicity assays with repeated doses in rodents and interventions in clinical trials. Graphic
- 31 January 2024
- Published by Springer Nature in Future Journal of Pharmaceutical Sciences
- Vol. 10 (1) , 1-22
Open AccessComprehensive preclinical studies on the bioactivity of Orbignya phalerata Mart. (Babassu) and its derived products: a systematic review
Background: Babassu (Orbignya phalerata Mart.) is a palm tree well distributed in Latin America, whose fruit has a mesocarp and kernel used for human feeding, and empirically related to the treatment of gastritis, vaginitis, and wound healing. Main body of the The activities attributed to babassu can guide new research on health applications and, for this reason, this study aimed to report in vitro and in vivo biological activities of O. phalerata constituents through a systematic review. Searches terms were applied in five world databases and the data from the publications were collected according to PICOS criteria, including the fruit component, concentration/dose, time of exposure, and comparative groups. All outcomes were reported and the most relevant outcomes were described by a narrative synthesis and a risk of bias assessment. A total of 28 in vitro (n = 15) and in vivo (n = 11) studies were included, and two showed both experimental designs. The studies were heterogeneous, with the predominance of metabolic analysis, wound and peptic ulcer healing, besides in vivo toxicity, among others. For in vitro analysis, antioxidant tests, cell viability and antimicrobial activity predominated. All in vivo ones used rodents. Meanwhile, tumor and non-tumor cell lines, bacteria strains, Leishmania amazonensis, Artemia salina, and antioxidant reactions were considered for in vitro protocols. Short conclusion: The most frequent applications included mesocarp and kernel in a wide range of extracts, emulsions, and concentrations. Their low in vitro lethality and cytotoxicity, and no acute toxicity in vivo open possibilities for the development of long-term toxicity assays with repeated doses in rodents and interventions in clinical trials. Graphic